Weight-bearing Diagnostics in Acute Lisfranc Injury: CT vs X-ray
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT05799807 |
Recruitment Status :
Recruiting
First Posted : April 5, 2023
Last Update Posted : April 20, 2023
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
Condition or disease | Intervention/treatment | Phase |
---|---|---|
Lisfranc Injury Foot Sprain | Procedure: Conservative treatment Procedure: Minimally invasive stabilization | Not Applicable |
Injury to the tarsometatarsal (TMT) joint complex in the midfoot is referred to as a Lisfranc injury. The broad spectrum of these injuries includes simple sprains to severe fracture-dislocations. Variable clinical presentations and radiographic findings make Lisfranc injuries notoriously difficult to detect, especially in the case of subtle ligament injuries. Nowadays, up to 30% of unstable Lisfranc injuries are overlooked or misdiagnosed. This can potentially lead to severe sequelae such as post-traumatic osteoarthritis and foot deformities.
For obvious injuries involving diastasis, subluxation, or dislocation, the diagnosis is relatively easy to establish using any imaging modality. However, for subtle injuries without gross bone separation, a dynamic imaging modality facilitating weight-bearing are to be preferred. Many consider weight-bearing conventional radiography as the current gold standard in acute Lisfranc injury diagnostics. However, conventional radiography is a 2D technique that can neither display nor measure the true dimensions of a detailed 3D object, such as the tarsal bones in the foot. Computed tomography (CT) provides greater accuracy in visualizing bone microarchitecture. In combination with weight-bearing, it can be ideal for detecting minor fractures and occult instability caused by load/stress.
To this day, there are no prospective studies comparing weight-bearing CT and weight-bearing radiography for acute Lisfranc injuries. In the current study, participants will be assigned to non-operative or operative treatment based on Lisfranc joint stability evaluation by the initial weight-bearing CT.
Study Type : | Interventional (Clinical Trial) |
Estimated Enrollment : | 50 participants |
Allocation: | Non-Randomized |
Intervention Model: | Parallel Assignment |
Intervention Model Description: | Acute Lisfranc injuries are investigated with weight-bearing diagnostics to determine the degree of TMT stability. Patients are examined using both CT and conventional radiography during full weight and non-weight-bearing sequences. 3 foot- and ankle surgeons will examine the scans independently, starting with the conventional radiographs. Distance between the medial cuneiform and second metatarsal bone (C1-M2) is measured. For the CT images, measuring method previously described by Y. Sripanich et al. (DOI: 10.1007/s00402-020-03477-5) will be used. CT findings will determine the treatment outcome. If the C1-M2 diastasis is >2mm, as opposed to the uninjured side, the injury will be determined unstable and surgical fixation will be recommended (Cohort 2). All other patients (≤ 2mm) are considered stable and treated conservatively (Cohort 1). |
Masking: | None (Open Label) |
Primary Purpose: | Diagnostic |
Official Title: | Weight-bearing Diagnostics in Acute Lisfranc Injury: A Prospective Study Comparing Computed Tomography Versus Conventional Radiography |
Actual Study Start Date : | April 18, 2023 |
Estimated Primary Completion Date : | April 18, 2024 |
Estimated Study Completion Date : | April 18, 2025 |
Arm | Intervention/treatment |
---|---|
Active Comparator: Cohort 1 - Conservative
Negative weight-bearing CT (≤ 2mm between C1-M2, as opposed to the uninjured side) will be considered stable and treated conservatively with a prefabricated walker with weight-bearing as tolerated for six weeks. These patients will undergo bilateral radiographs after six weeks and combined CT and radiographs after twelve weeks to monitor the degree of stability
|
Procedure: Conservative treatment
Patients with negativ weight-bearing CT will be treated conservative |
Active Comparator: Cohort 2 - Surgical
Positive weight-bearing CT (> 2mm between C1-M2, as opposed to the uninjured side) will be operated by minimally invasive stabilization (eg, isolated homerun screw)
|
Procedure: Minimally invasive stabilization
Patients with positive weight-bearing CT will be operated by minimally invasive stabilization (eg, isolated homerun screw) |
- Manchester-Oxford Foot Questionnaire (MOxFQ) [ Time Frame: 1 year ]Foot-Ankle specific PROM (0-100 with 0 representing the best possible outcome)
- American Orthopaedic Foot and Ankle Society (AOFAS) Ankle-Midfoot score [ Time Frame: 1 year ]Foot-Ankle specific PROM (0-48 with 48 representing the best possible outcome)
- Visual Analogue Scale (VAS) for pain [ Time Frame: 1 year ]Scores pain at rest and on activity (0-10 with 0 representing no pain)
- Short-Form (SF) 36 [ Time Frame: 1 year ]Patient reported score measuring quality of life and health status (0-100 with 100 representing the best possible outcome)
- Posttraumatic osteoarthritis [ Time Frame: 1 year ]The presence of osteoarthritis of the tarsometatarsal joints using the Kellgren & Lawrence classification system
- Incidence of complications [ Time Frame: 1 year ]Yes/no for deep or superficial infection, nerve or tendon injury, deep venous thrombosis, hardware complaints and secondary surgery. Regards the patients that have undergone surgical treatment.
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study: | 18 Years to 70 Years (Adult, Older Adult) |
Sexes Eligible for Study: | All |
Accepts Healthy Volunteers: | Yes |
Inclusion Criteria:
- Acute trauma to the midfoot
- Intraarticular fracture and/or avulsion fracture in the TMT joint line (detected on a non-weight-bearing CT)
- Suspicion of a purely ligamentous Lisfranc injury (no radiological fractures but substantial clinical findings in the midfoot region, or evidence of ligamentous damage on a MRI)
- Consent-competent patient
Exclusion Criteria:
- Obvious acute unstable Lisfranc injuries (>2mm dislocation between the medial cuneiform and second metatarsal)
- Injury older than four weeks
- Other major foot/ankle/leg injuries
- Previous foot infection or foot pathology on the affected side
- Previous surgery to the TMT joints, and sequelae after a previous foot injury
- Open injury
- Bilateral injury
- Patients with co-morbidities such as neuropathy and peripheral vascular disease
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT05799807
Contact: Magnus Poulsen, MD | +4797729404 | japoul@ous-hf.no | |
Contact: Are Stødle, MD PhD | +4797174507 | arhauk@ous-hf.no |
Norway | |
Oslo University Hospital, Ullevål | Recruiting |
Oslo, Norway, 0450 | |
Contact: Stephan Röhrl, MD, PhD +4794424677 UXRHST@ous-hf.no |
Principal Investigator: | Magnus Poulsen, MD | Oslo University Hospital |
Responsible Party: | Magnus Poulsen, Principal Investigator, Oslo University Hospital |
ClinicalTrials.gov Identifier: | NCT05799807 |
Other Study ID Numbers: |
110364 |
First Posted: | April 5, 2023 Key Record Dates |
Last Update Posted: | April 20, 2023 |
Last Verified: | April 2023 |
Individual Participant Data (IPD) Sharing Statement: | |
Plan to Share IPD: | No |
Studies a U.S. FDA-regulated Drug Product: | No |
Studies a U.S. FDA-regulated Device Product: | No |
Wounds and Injuries |